AIM ImmunoTech (AIM) is scheduled to report Q2 earnings on August 14, 2026. Analysts estimate EPS of $-0.12 and quarterly revenue of N/A.
AIM ImmunoTech has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, AIM ImmunoTech has averaged an EPS surprise of 0.62% and a revenue surprise of 0.80%.
Analyze the earnings history of AIM ImmunoTech using advanced sorting and filters.
The chart below shows AIM ImmunoTech's reported EPS compared to analyst estimates over recent quarters.
The chart below shows AIM ImmunoTech's reported revenue compared to analyst estimates over recent quarters.
AIM ImmunoTech (AIM) is scheduled to report earnings on August 14, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.
The Actual EPS was $-0.69, which missed the estimate of $0.00.
The Actual Revenue was $22.00K, which beat the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2026-03-27 | $-1.44 | $-1.08 | -33.3 % |
| Q3 | 2025-11-18 | $-1.57 | $-0.98 | -60.2 % |
| Q2 | 2025-08-14 | $-3.68 | $-8.00 | 54.0 % |
| Q1 | 2025-05-15 | $-0.05 | $-8.00 | 99.4 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $25.00K | $100.00K | -75.0 % |
| Q1 | 2025-05-15 | $16.00K | $100.00K | -84.0 % |
| Q4 | 2025-03-27 | $45.00K | $45.00K | 0.00 % |
| Q3 | 2024-11-15 | $35.00K | $11.67K | 199.9 % |